Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Anusuya Lahiri

Analysts Slash Their PTs On Oracle As They Did Not Buy Its Growth Story

  • Analysts slashed their price targets on Oracle Corp (NYSE:ORCLpost Q3 results.
  • Piper Sandler analyst Brent Bracelin downgraded to Underweight from Neutral with a PT of $70 (8.7% downside), down from $100. 
  • Bracelin found it challenging to reach double-digit organic growth next year, sustaining a cloud shift considering more than 70% of revenue came from the traditional Oracle product categories.
  • BofA analyst Brad Sills lowered the PT to $90 from $105 (17.4% upside) and kept a Neutral. 
  • Sills also did not buy the company's cloud outlook and margin expansion story.
  • Wolfe Research analyst Alex Zukin lowered the PT to $83 from $105 (8.3% upside) peer multiple contractions and kept a Peer Perform. 
  • Zukin noted "strong" fiscal Q3 results with accelerating constant-currency revenue coupled with double-digit sales growth and expanding margins for fiscal 2023.
  • Price Action: ORCL shares traded higher by 1.95% at $78.12 on the last check Friday.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.